ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Technology-Driven Performance Improvement of a Biomarker Panel in Kidney Transplant: OmniGraf

P. West-Thielke, C. Miller, N. Grund, A. Sutton, R. Sinha, M. Miller, S. Kleiboeker, J. Weems

Eurofins, Framingham, MA

Meeting: 2022 American Transplant Congress

Abstract number: 1569

Keywords: Gene expression, Polymerase chain reaction (PCR), Rejection

Topic: Basic Science » Basic Clinical Science » 17 - Biomarkers: Clinical Outcomes

Session Information

Session Name: Biomarkers: Clinical Outcomes

Session Type: Poster Abstract

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Analyze the impact of the transition from TruGraf microarray to TruGraf PCR on the complementary performance characteristics of TruGraf plus TRAC (OmniGraf).

*Methods: Development of the TruGraf assay was originally performed via a high-throughput analysis of gene expression on a microarray system. Microarray, while useful as a discovery tool, is a source of high assay variability and can have results influenced by the complex hybridization assay. It is also time-consuming, labor-intensive, and requires large amounts of pure RNA. This leads to a turnaround time of at least 7 days. Using RT-PCR and microfluidics (Fluidigm Biomark HD) provides more rapid and quantitative analysis of gene expression, while requiring less RNA input and substantially reducing turnaround time. We performed analytical and clinical validation between the RT-PCR and microarray processes. TruGraf results of “TX” are considered negative and “not-TX” are considered positive while TRAC results of <0.7% are considered negative and results of ≥ 0.7% are considered positive.

*Results: The NPV increased from 88% to 94% when both assays were negative. The PPV increased from 81% to 89% when both tests were positive (Figure 1A/B). False negative results were reduced from 31% to 17%, while true negative results improved from 74% to 81%. 26.2% of results were positive for one test and negative for the other: 11.7% showed elevated TRAC (+) and a TX TruGraf (-); 14.5% showed a TruGraf not-TX (+) and low TRAC score (-). A previous report noted that TruGraf was significantly better at detecting subclinical TCMR and TRAC was significantly better at detecting subclinical ABMR; however, this improvement in TruGraf technology increased its detection of all subtypes of rejection (Figure 1C).

*Conclusions: In the field of transplant biomarkers where high NPV values have been the focus we present novel clinical validation data on the first commercial biomarker panel with a high PPV. With the data presented here, TruGraf PCR plus TRAC (OmniGraf) results provide a high probability of either immune quiescence or subclinical rejection to support clinical decision-making.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

West-Thielke P, Miller C, Grund N, Sutton A, Sinha R, Miller M, Kleiboeker S, Weems J. Technology-Driven Performance Improvement of a Biomarker Panel in Kidney Transplant: OmniGraf [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/technology-driven-performance-improvement-of-a-biomarker-panel-in-kidney-transplant-omnigraf/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences